Clinical reference Biomarker Directory
Back to directory

Pancreatic Amylase

Established

Pancreatic amylase is the pancreas-specific fraction of amylase, sharing amylase's overall decline in favor of lipase.

Also known as P-type amylase pancreatic isoamylase
In plain language

This is the pancreas-specific portion of the amylase enzyme, distinguished from the salivary-gland portion. Like general amylase, it has mostly been replaced by lipase testing for diagnosing pancreatitis.

Biomarker & context

Pancreatic amylase is the pancreas-specific isoenzyme fraction of total serum amylase, distinguishing pancreatic-source amylase elevation from the roughly 40% of circulating amylase that originates from salivary glands and other tissues.

What it indicates

See "Amylase" for the broader clinical context — pancreatic amylase isoenzyme testing shares the same general decline in favor of lipase for pancreatitis diagnosis, since guidelines now recommend against amylase testing (isoenzyme or total) for this purpose.

Diagnosis & clinical testing

Measured via isoenzyme electrophoresis or specific immunoassay when isolating the pancreatic fraction is clinically relevant; in practice, this is rarely ordered given lipase's superior performance for pancreatitis diagnosis.

Guiding treatment

As with total amylase, current guidelines do not recommend serial monitoring of pancreatic amylase to track pancreatitis severity or recovery.

Clinical significance

Rarely ordered in current practice given lipase's superior diagnostic performance for pancreatitis.

References
  1. AAFP. (2017). Don't test for amylase in cases of suspected acute pancreatitis. Instead, test for lipase.